Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029463 (
osteosarcoma
)
16,637
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The pituitary tumor transforming gene,
PTTG
, is abundantly expressed in several neoplasms. We recently showed that
PTTG
overexpression is associated with apoptosis and therefore have now studied the role of p53 in this process. In MCF-7 breast cancer cells that express wild type p53,
PTTG
overexpression caused apoptosis. p53 was translocated to the nuclei in cells expressing
PTTG
. Overexpression of p53, along with
PTTG
, augmented apoptosis, whereas expression of the human papillomavirus E6 protein inhibited
PTTG
-induced apoptosis. In MG-63
osteosarcoma
cells that are deficient in p53,
PTTG
caused cell cycle arrest and subsequent apoptosis that was inhibited by caspase inhibitors. A proteasome inhibitor augmented
PTTG
expression in stable
PTTG
transfectants, suggesting that down-regulated
PTTG
expression is required for cell survival. Finally, MG-63 cells expressing
PTTG
showed signs of aneuploidy including the presence of micronuclei and multiple nuclei. These results indicate that
PTTG
overexpression causes p53-dependent and p53-independent apoptosis. In the absence of p53,
PTTG
causes aneuploidy. These results may provide a mechanism for
PTTG
-induced tumorigenesis whereby
PTTG
mediates aneuploidy and subsequent cell transformation.
...
PMID:Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis. 1101 29